Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets

Clear cell renal cell carcinoma (ccRCC) is the most frequent histological kidney cancer subtype. Over the last decade, significant progress has been made in identifying the genetic and metabolic alterations driving ccRCC development. In particular, an integrated approach using transcriptomics, metab...

Descripción completa

Detalles Bibliográficos
Autores principales: di Meo, Nicola Antonio, Lasorsa, Francesco, Rutigliano, Monica, Loizzo, Davide, Ferro, Matteo, Stella, Alessandro, Bizzoca, Cinzia, Vincenti, Leonardo, Pandolfo, Savio Domenico, Autorino, Riccardo, Crocetto, Felice, Montanari, Emanuele, Spilotros, Marco, Battaglia, Michele, Ditonno, Pasquale, Lucarelli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698586/
https://www.ncbi.nlm.nih.gov/pubmed/36430837
http://dx.doi.org/10.3390/ijms232214360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698586/
https://www.ncbi.nlm.nih.gov/pubmed/36430837
http://dx.doi.org/10.3390/ijms232214360

Ejemplares similares